FR2430942A1 - Preparation de derives o-methyliques d'hydroxyaporphines - Google Patents

Preparation de derives o-methyliques d'hydroxyaporphines

Info

Publication number
FR2430942A1
FR2430942A1 FR7835193A FR7835193A FR2430942A1 FR 2430942 A1 FR2430942 A1 FR 2430942A1 FR 7835193 A FR7835193 A FR 7835193A FR 7835193 A FR7835193 A FR 7835193A FR 2430942 A1 FR2430942 A1 FR 2430942A1
Authority
FR
France
Prior art keywords
hydroxyaporphins
preparation
methyl derivatives
derivatives
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835193A
Other languages
English (en)
Other versions
FR2430942B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of FR2430942A1 publication Critical patent/FR2430942A1/fr
Application granted granted Critical
Publication of FR2430942B1 publication Critical patent/FR2430942B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

La présente invention a pour objet un procédé pour réaliser la O-méthylation d'hydroxyaporphines. Les groupes hydroxy-phénoliques d'un composé de formule générale :
FR7835193A 1977-12-22 1978-12-14 Preparation de derives o-methyliques d'hydroxyaporphines Granted FR2430942A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2757335A DE2757335C3 (de) 1977-12-22 1977-12-22 Verfahren zur O-Methylierung von Hydroxyaporphinen

Publications (2)

Publication Number Publication Date
FR2430942A1 true FR2430942A1 (fr) 1980-02-08
FR2430942B1 FR2430942B1 (fr) 1985-02-22

Family

ID=6026924

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7835193A Granted FR2430942A1 (fr) 1977-12-22 1978-12-14 Preparation de derives o-methyliques d'hydroxyaporphines

Country Status (14)

Country Link
US (1) US4309542A (fr)
JP (1) JPS54119474A (fr)
AT (1) AT362535B (fr)
BE (1) BE872843A (fr)
CH (1) CH645629A5 (fr)
CS (1) CS238601B2 (fr)
DD (1) DD141830A5 (fr)
DE (1) DE2757335C3 (fr)
FI (1) FI68222C (fr)
FR (1) FR2430942A1 (fr)
GB (1) GB2010841B (fr)
HU (1) HU177060B (fr)
NL (1) NL7812394A (fr)
SU (1) SU925249A3 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118521A1 (de) * 1981-05-09 1982-12-02 Gödecke AG, 1000 Berlin Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien
US4795759A (en) * 1985-07-27 1989-01-03 Sandoz Ltd. Use of dibenz(CD,F)indoles
US6210680B1 (en) 1999-06-11 2001-04-03 Univera Pharmaceuticals, Inc. Method for the prevention and treatment of chronic venous insufficiency
TWI225397B (en) * 2000-05-04 2004-12-21 Nat Science Council Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of the same
PT1311486E (pt) * 2000-08-23 2006-09-29 Lotus Pharmaceutical Co Ltd Uso de taliporfina ou dos seus derivados no tratamento de doencas cardiacas e preparacao da mesma
CA2531406A1 (fr) * 2003-06-19 2004-12-23 Lotus Pharmaceutical Co., Ltd. Aporphine et oxoaporphine et leur utilisation a des fins medicales
CN1884265A (zh) * 2005-06-20 2006-12-27 美时化学制药股份有限公司 治疗糖尿病的阿朴芬及次阿朴芬化合物
WO2007134485A1 (fr) * 2006-05-22 2007-11-29 Lotus Pharmaceutical Co., Ltd. Composés aporphiniques et oxoaporphiniques et utilisation pharmaceutique correspondante
TWI531369B (zh) * 2014-05-30 2016-05-01 資元堂生物科技股份有限公司 阿朴啡生物鹼衍生物用於製備促進ａｍｐｋ活性的藥物之用途
CN111196801B (zh) * 2020-01-14 2022-10-14 中国药科大学 阿朴菲类生物碱衍生物及其制备方法与用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2337507A1 (de) * 1973-07-24 1975-02-13 Research Corp Verfahren zur herstellung von aporphinen ueber neue zwischenprodukte
FR2353534A1 (fr) * 1976-06-04 1977-12-30 Warner Lambert Co Derives nouveaux de 4-hydroxy-aporphine, leur mode preparation et leur application pharmacologique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1100998A (en) * 1912-05-06 1914-06-23 Firm Of Mckesson & Robbins Process of manufacuring alkyl-ethers of morphin.
GB1364318A (en) * 1971-03-15 1974-08-21 Bellon Labor Sa Roger Laurotetanine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2337507A1 (de) * 1973-07-24 1975-02-13 Research Corp Verfahren zur herstellung von aporphinen ueber neue zwischenprodukte
FR2353534A1 (fr) * 1976-06-04 1977-12-30 Warner Lambert Co Derives nouveaux de 4-hydroxy-aporphine, leur mode preparation et leur application pharmacologique

Also Published As

Publication number Publication date
DD141830A5 (de) 1980-05-21
US4309542A (en) 1982-01-05
GB2010841A (en) 1979-07-04
FR2430942B1 (fr) 1985-02-22
AT362535B (de) 1981-05-25
CH645629A5 (de) 1984-10-15
JPS54119474A (en) 1979-09-17
FI783951A (fi) 1979-06-23
ATA913578A (de) 1980-10-15
FI68222B (fi) 1985-04-30
DE2757335C3 (de) 1982-03-25
SU925249A3 (ru) 1982-04-30
GB2010841B (en) 1982-08-18
DE2757335A1 (de) 1979-06-28
FI68222C (fi) 1985-08-12
NL7812394A (nl) 1979-06-26
BE872843A (fr) 1979-04-17
CS238601B2 (en) 1985-12-16
DE2757335B2 (de) 1981-05-27
HU177060B (hu) 1981-06-28

Similar Documents

Publication Publication Date Title
FR2391187A1 (fr) (meth)acryloxy-alkylpropanals utiles pour la preparation de polymeres a groupes carbonyle
FR2355028A1 (fr) Procede pour la preparation de glycosides derives d'anthracyclines optiquement actives
FR2430942A1 (fr) Preparation de derives o-methyliques d'hydroxyaporphines
FR2398065A1 (fr)
FR2395269A1 (fr) Procede de preparation de 7,8-dihydro-14-hydroxynormorphinone
FR2377367A1 (fr) Procede de preparation d'alcoxy-cetones
FR2445318A1 (fr) Procede de preparation de 1-(3-mercapto-propanoyl)-l-prolines
FR2371460A1 (fr) Procede de preparation de kanamycine c et de ses derives desoxy
FR2355834A1 (fr) Procede de preparation des 1-phenyl-3-amino pyrazoles
FR2422675A1 (fr) Procede de fabrication de n-phosphonomethyl-glycine et de ses derives
FR2361352A1 (fr) Derives acylamino (alkyl)-benzeniques, leur procede de preparation et leur application
FR2374291A1 (fr)
FR2369249A1 (fr) Derives an
FR2358380A1 (fr) Procede pour la preparation de cetones cycliques
FR2397417A1 (fr) Procede de preparation de derives de la thienopyridine
FR2389608A1 (fr)
FR2354317A1 (fr) Benzyl-cyanoacetals, leur preparation et leur utilisation pour des syntheses chimiques
FR2398047A1 (fr) Procede de preparation d'a-cetocarbonamides n-substitues et produits obtenus par ce procede
FR2373535A1 (fr)
FR2383933A1 (fr) Procede de preparation de 2,4-dioxo-oxazolidines
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
FR2367721A1 (fr) Procede de preparation d'ethers alkyliques tertiaires
FR2381768A1 (fr) Procede pour preparer des composes chromeno-indole
FR2372834A1 (fr) Derives de l'ergoline
FR2429790A1 (fr) Synthese totale de la substance utero-evacuante d,l-zoapatanol, derivee de la plante zoapatle

Legal Events

Date Code Title Description
ST Notification of lapse